Related Experiment Videos
Autologous tissue-engineered trachea with sheep nasal chondrocytes
Koji Kojima1, Lawrence J Bonassar, Amit K Roy
1Center for Tissue Engineering, University of Massachusetts Medical School, Worcester, 01603-3122, USA.
The Journal of Thoracic and Cardiovascular Surgery
|June 14, 2002
Summary
This study shows that a helix-shaped, autologous tissue-engineered trachea can form a functional tracheal replacement. This regenerative medicine approach shows promise for patients requiring tracheal resection.
Area of Science:
- Regenerative Medicine
- Biomaterials Science
- Surgical Innovation
Background:
- Tracheal defects pose significant challenges in reconstructive surgery.
- Current treatments for tracheal defects have limitations.
- Tissue engineering offers a potential solution for creating functional tracheal replacements.
Purpose of the Study:
- To evaluate the feasibility of using autologous tissue-engineered trachea shaped in a helix for tracheal replacement.
- To assess the structural integrity and biocompatibility of the engineered trachea.
- To determine the potential of this approach for clinical application.
Main Methods:
- Autologous nasal septum was harvested from sheep to isolate chondrocytes and fibroblasts.
- Cells were seeded onto polyglycolic acid meshes and shaped into a helical template.
- Engineered tracheas were implanted in nude rats and sheep for evaluation of histology, biochemistry, and surgical integration.
Main Results:
- Tissue-engineered tracheas exhibited gross and tissue morphology similar to native tracheas.
- Histological analysis revealed mature cartilage and connective tissue formation.
- Biochemical analysis showed comparable collagen and cell content to native tracheal tissue, with some variations in proteoglycan levels.
Conclusions:
- Autologous tissue engineering can successfully recreate the cartilage and fibrous components of the trachea.
- This method provides a feasible approach for tracheal reconstruction using a single tissue harvest.
- The study demonstrates potential benefits for individuals requiring tracheal resection.